India to Amend Drug and Clinical Trial Rules to Streamline Approval Process
New Delhi, September 3 (HS): In a major regulatory reform aimed at easing compliance in the pharmaceutical and clinical research sectors, the Union Health Ministry has proposed amendments to the New Drugs and Clinical Trials Rules, 2019. The draft ch
Invalid email address
संपर्क करें
हिन्दुस्थान समाचार बहुभाषी न्यूज एजेंसी एम-6, भगत सिंह मार्केट, गोल मार्केट, नई दिल्ली- 110001
(+91) 7701802829 / 7701800342
Related News
